Abstract: A system for maintaining links and revisions for documents is described. The system comprises a productivity server configured to provide a document collaboration service and having processors and a memory storing program data. The program data configures the processors to: receive requests indicating revisions on the documents, including a first request that indicates a first revision to a first document, and a second request that indicates a second revision to a second document. For each request, a workspace revision counter shared by, and indicating a revision state of, the documents is incremented. The workspace revision counter is incremented a first time for the first request and a second time for the second request. Revisions corresponding to the each request are queued in a workspace revision queue shared by the documents. The revisions are caused to be performed on the documents that correspond to the each request.

Abstract: Provided herein are compounds of the Formula (I): and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein R1, R2, R9, X1 and G are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.

Abstract: A system for maintaining links and revisions for documents is described. The system comprises a productivity server configured to provide a document collaboration service and having processors and a memory storing program data. The program data configures the processors to: receive requests indicating revisions on the documents, including a first request that indicates a first revision to a first document, and a second request that indicates a second revision to a second document. For each request, a workspace revision counter shared by, and indicating a revision state of, the documents is incremented. The workspace revision counter is incremented a first time for the first request and a second time for the second request. Revisions corresponding to the each request are queued in a workspace revision queue shared by the documents. The revisions are caused to be performed on the documents that correspond to the each request.

Abstract: Provided herein are compounds of the Formula (I): and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein R1, R2, R9, X1 and G are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.

Abstract: A method for maintaining links and revisions for a plurality of documents is described. The method is carried out by one or more computing devices. Requests that indicate revisions to be carried out on the plurality of documents are received, at least one of the requests corresponding to revisions for different documents of the plurality of documents. For each request: a workspace revision counter that is shared by the plurality of documents is incremented, the workspace revision counter indicating a revision state of the plurality of documents, the revision is queued in a workspace revision queue that is shared by the plurality of documents, and the revision indicated by the request is caused to be performed on one or more documents of the plurality of documents that correspond to the request.

Abstract: A method for maintaining links and revisions for a plurality of documents is described. The method is carried out by one or more computing devices. Requests that indicate revisions to be carried out on the plurality of documents are received, at least one of the requests corresponding to revisions for different documents of the plurality of documents. For each request: a workspace revision counter that is shared by the plurality of documents is incremented, the workspace revision counter indicating a revision state of the plurality of documents, the revision is queued in a workspace revision queue that is shared by the plurality of documents, and the revision indicated by the request is caused to be performed on one or more documents of the plurality of documents that correspond to the request.

Abstract: Provided herein are compounds of the Formula I: and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein R1, R2, R9, X1 and G are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.

Abstract: A method for maintaining links and revisions for a plurality of documents is described. The method is carried out by one or more computing devices. Requests that indicate revisions to be carried out on the plurality of documents are received, at least one of the requests corresponding to revisions for different documents of the plurality of documents. For each request: a workspace revision counter that is shared by the plurality of documents is incremented, the workspace revision counter indicating a revision state of the plurality of documents, the revision is queued in a workspace revision queue that is shared by the plurality of documents, and the revision indicated by the request is caused to be performed on one or more documents of the plurality of documents that correspond to the request.

Abstract: Provided herein are compounds of the Formula I: and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein R1, R2, R9, X1 and G are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.

Abstract: The present invention relates to indoline and indolenine alkaloid compounds. In particular, indoline and indolenine alkaloid compounds of the invention have antibacterial activity and/or are capable of re-sensitizing the susceptibility of methicillin-resistant S. aureus to a ?-lactam antibiotic. The present invention also relates to a method for producing and using the same.

Abstract: The present invention relates to indoline and indolenine alkaloid compounds. In particular, indoline and indolenine alkaloid compounds of the invention have antibacterial activity and/or are capable of re-sensitizing the susceptibility of methicillin-resistant S. aureus to a ?-lactam antibiotic. The present invention also relates to a method for producing and using the same.